MedPath

TALTZ

TALTZ

Approved
DIN Number

02455102

Drug Class

Human

Market Date

Aug 11, 2016

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02455102
AIG Number0158170001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AC13 IXEKIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

IXEKIZUMABActive
Strength: 80 MG / ML
Monograph: IXEKIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.